Purpose
To evaluate the clinical significance of pneumatosis intestinalis (PI) including the influence on patients' management and outcome
Methods and materials

Method and Materials
This single-centre retrospective study was approved by our institutional ethics committee. Patients' active consent was waived.
Two radiologists, blinded to any clinical and therapeutical information, jointly reviewed MDCT-examinations of 149 consecutive patients (53 women, mean age 64) with PI of the stomach (n=4), small (n=68) and/or large bowel (n=96). PI extension, distribution and possibly associated portomesenteric venous gas (PMVG) were then correlated with other MDCT-findings, risk factors, clinical management, laboratory, histopathology, final diagnosis and outcome (see Table 1 ) 
Statistical analysis
Categorical variables were compared with the Chi-square or Fisher's test, for continuous variables the student's test or the analysis of variance (ANOVA) were applied. Statistical difference was considered significant for a p-value <0.05.
Results
Intravenously given iodinated contrast-enhanced MDCT-acquisition had been performed in 103 patients (69.1%), while 46 (30.8%) of patients underwent non-enhanced MDCT only.
Pneumatosis intestinalis was located in the gastric wall in four patients (2.7%), in the small bowel wall in 68 (45.6%), and in the colonic wall in 96 (64.4%) patients. Among them, PI was observed in one patient in the stomach and small bowel wall simultaneously, and in 18 (12.1%) patients in the small and large bowel wall simultaneously.
The most frequent cause of PI was bowel ischemia (n=80, 53.7%, Fig. 1 and Fig.  2 ), followed by infection (n=18, 12.1%), obstructive (n=12, 8.1%) and non-obstructive (n=10, 6.7%) bowel dilatation, drugs (n=8,5.4%), unknown aetiologies (n=8,5.4%, Fig.  3 ), inflammation (n=7,4.7%), and others (n=6,4%).
The localisation of PI caused by ischemia was the stomach in 2 patients, the small bowel in 42 patients, and the colon in 48 patients.
Neither location nor extension of PI significantly correlated with underlying ischemia (p=0.824).
Concomitant PMVG with PI was significantly associated with underlying ischemia (p=0.001), and also the four sites of distribution of PMVG (Table 2) , with the exception of gas in the superior mesenteric vein.
Among all the evaluated radiological MDCT-signs, only the feature "absent mural contrast-enhancement" significantly correlated with underlying ischemia (p=7.48x10 -6 ).
The degree of calcified atherosclerosis, as evaluated by the two radiologists on the MDCT-images, was significantly associated with PI due to bowel ischemia (p=0.024), unlike the anamnestic cardiovascular risk factors, we had found in the patients' records (p=0.723).
None of the clinical findings present at the time of MDCT acquisition significantly correlated with an ischemic origin of PI ( Table 2 ).
As to the laboratory tests, only the white blood cell count was statistically significantly associated with underlying bowel ischemia (p=0.008), while the pH showed a tendency for an ischemic origin of PI (p=0.0505), unlike the serum lactate and the blood urea (Table  2) .
Concerning the choice of treatment, the ischemic origin of PI was significantly related with the choice of a surgical treatment (p=1.747x10 -6 ), instead of conservative management, and even with curative surgery (p=0.0122), instead of exploratory only.
Overall mortality was 41.6% (n=62), mostly related to intestinal ischemia (p=0.003). The patients with PI caused by ischemia were significantly older (67.9 years) than the patients with PI resulting from other causes (59.4 years, p=0.00067). However, in the group with PI due to bowel ischemia, the fatal outcome did not depend on the age of the patient. Images for this section: 
